| scholarly article | Q13442814 |
| P2093 | author name string | Satoshi Matsumoto | |
| Taeko Hara | |||
| Yoshinori Umesaki | |||
| Hiromi Setoyama | |||
| Kimitoshi Kato | |||
| Shigeaki Mizuno | |||
| Toshiki Uehara | |||
| Tatsuichiro Shima | |||
| Akemi Imaoka | |||
| P2860 | cites work | Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial | Q24685494 |
| Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine | Q24685766 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. | Q30873571 | ||
| Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria | Q33787825 | ||
| Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation | Q33945974 | ||
| A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei | Q33947106 | ||
| Colonization of the stratified squamous epithelium of the nonsecreting area of horse stomach by lactobacilli | Q33988135 | ||
| A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding | Q34499168 | ||
| A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease | Q34529230 | ||
| Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics | Q35787456 | ||
| Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport | Q40557124 | ||
| Augmentation of anti-influenza virus hemagglutinin antibody production by Peyer's patch cells with Bifidobacterium breve YIT4064 | Q40672384 | ||
| Probiotic bacteria enhance murine and human intestinal epithelial barrier function | Q40783633 | ||
| Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis | Q43867015 | ||
| Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis | Q45166043 | ||
| Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. | Q47777664 | ||
| Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. | Q49073992 | ||
| Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis | Q52477532 | ||
| Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. | Q53584174 | ||
| Cortisone in ulcerative colitis; final report on a therapeutic trial. | Q55499879 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Lack of Interleukin-10 Leads to Intestinal Inflammation, Independent of the Time at Which Luminal Microbial Colonization Occurs | Q59120602 | ||
| Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease | Q72189511 | ||
| Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease | Q73234078 | ||
| Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice | Q77089238 | ||
| Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? | Q77375025 | ||
| Colitis-related public T cells are selected in the colonic lamina propria of IL-10-deficient mice | Q77757690 | ||
| Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients | Q79547624 | ||
| Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis | Q83333118 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ulcerative colitis | Q1477 |
| inflammation | Q101991 | ||
| probiotics | Q1816730 | ||
| patient | Q181600 | ||
| P304 | page(s) | 2511-2516 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells | |
| P478 | volume | 14 |
| Q88766681 | A Probiotic for Ulcerative Colitis: The Culture Wars Continue |
| Q84534111 | A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer |
| Q36277139 | A two-component regulatory system controls autoregulated serpin expression in Bifidobacterium breve UCC2003. |
| Q36128689 | An In Vitro Approach to Study Effects of Prebiotics and Probiotics on the Faecal Microbiota and Selected Immune Parameters Relevant to the Elderly |
| Q34297879 | An important role of interleukin-10 in counteracting excessive immune response in HT-29 cells exposed to Clostridium butyricum |
| Q101121192 | Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice |
| Q39866028 | Anti-inflammatory effects of the genus Bifidobacterium on macrophages by modification of phospho-I kappaB and SOCS gene expression |
| Q44410046 | Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection. |
| Q39450357 | Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. |
| Q58327060 | Bifidobacterium animalis ssp. lactis Bb12 induces IL-10 through cell membrane-associated components via TLR2 in swine |
| Q39653740 | Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells |
| Q42580341 | Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. |
| Q48262909 | Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice |
| Q36166571 | Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells |
| Q35994281 | Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice |
| Q33427772 | Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases |
| Q34626740 | Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. |
| Q34060471 | Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model |
| Q35780928 | Does the buck stop with the bugs?: an overview of microbial dysbiosis in rheumatoid arthritis |
| Q89579435 | Effects of Live and Heat-Inactivated E. coli Strains and Their Supernatants on Immune Regulation in HT-29 Cells |
| Q38905606 | Effects of phytochemicals on in vitro anti-inflammatory activity of Bifidobacterium adolescentis |
| Q33901112 | Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes |
| Q49948526 | Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis |
| Q37118873 | Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis |
| Q51352921 | Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486. |
| Q37851431 | Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis |
| Q39171816 | Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: prebiotic actions of galangin, quercetin, and fisetin |
| Q46256251 | Functional properties of anti-inflammatory substances from quercetin-treated Bifidobacterium adolescentis. |
| Q38794312 | Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. |
| Q34384871 | Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation |
| Q58327085 | In vitrodifferential modulation of immune response by probiotics in porcine peripheral blood mononuclear cells |
| Q46242554 | Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention. |
| Q38548567 | Innate immunity and inflammatory bowel disease: a review of clinical evidence and future application |
| Q92190760 | Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma |
| Q35035752 | Lactobacilli regulate Staphylococcus aureus 161:2-induced pro-inflammatory T-cell responses in vitro |
| Q33890323 | Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells |
| Q54295984 | Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells. |
| Q35195891 | Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation? |
| Q34499067 | Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics |
| Q63284028 | Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model |
| Q38253720 | Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach |
| Q64969749 | Para-probiotics for Preterm Neonates-The Next Frontier. |
| Q90228845 | Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond |
| Q38374202 | Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability |
| Q38702350 | Rationale for Using of Bifidobacterium Probiotic Strains-Fermented Milk Against Colitis Based on Animal Experiments and Clinical Trials |
| Q61812588 | Role of Intestinal Microbiota in the Bioavailability and Physiological Functions of Dietary Polyphenols |
| Q27008261 | Role of Probiotics in health improvement, infection control and disease treatment and management |
| Q35530138 | Secreted factors from Bifidobacterium animalis subsp. lactis inhibit NF-κB-mediated interleukin-8 gene expression in Caco-2 cells |
| Q90224285 | The Potential Impact of Probiotics on the Gut Microbiome of Athletes |
| Q35181992 | The microbiota and helminths: sharing the same niche in the human host |
Search more.